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Abstract 
Human coronaviruses are responsible for a number of physiological ailments and include 
illnesses such as the common cold, Middle East Respiratory Syndrome (MERS), Severe 
Acute Respiratory Syndrome (SARS), Covid-19, and pneumonia (Fehr and Perlman 
2015; Yin and Wunderink 2018). While vaccines exist for a multitude of pathogenic 
viruses that exists today, human coronaviruses are not among those that possess a stable 
and efficacious vaccine available on the market(Ahmed 2017). The recent emergence in 
2012 of highly pathogenic human coronaviruses in the Middle East has resulted in 
research projects being established around the globe that seek to better understand and 
discover preventative vaccines and effective therapeutics to be used to combat these 
deleterious viruses (Coleman and Frieman 2014). This push for coronavirus research is 
further exacerbated due to the on-going pandemic of SARS-CoV-2 (Lake 2020). 
Immediately after infecting a cell, the +ssRNA genome of MHV is translated by 
cell ribosomes to produce two large polyproteins, which contain all of the necessary 
proteins required by the virus to copy its genome (Gadlage et al. 2010). In order to free 
up these proteins to work, a protease subunit of the polyprotein called nonstructural 
protein 5 (nsp5), cuts the polyprotein at 11 sites to activate the individual replication 
proteins (Perlman and Netland 2009; Stobart et al. 2012). Nsp5 activity is essential for 
virus replication making it a primary target for current inhibitor design efforts. Attempts 
to make an inhibitor against coronaviruses have targeted the active site and substrate 
binding sites of nsp5, however these attempts have failed to date (López-Otín and Bond 
2008). The need for antivirals and the development of a vaccine could not be more urgent 
as Sars-CoV-2 continues to impact every nation in the world. The emergence of Covid-19 
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over the course of the last five months has been a tumultuous period of time riddled with 
transition and panic around the globe. The manifestation of pathogens such as Covid-19 
is not a new happening. In fact, this is the third coronavirus outbreak that’s occurred 
since 2003 when the world watched Sars-CoV-1 begin to spread in China (Coleman and 
Frieman 2014). 
Models of the structure of MHV nsp5 exhibit a high level of conservation to the 
nsp5 structures of human clinical strains such as  Sars-CoV-2, HKU1, OC43, NL63, and 
229E which combine to cause 15% of the cases of the common cold (Zhu et al. 2005; 
Perlman and Netland 2009). A unique loop region found between two structural domains 
of nsp5 called the interdomain loop (IDL) has been poorly characterized. In this study, I 
aim to determine the role of the MHV IDL through the analysis of a series of viral 
mutations introduced throughout the IDL region of the virus genome. 
Introduction 
With the recent emergence of the novel SARS-CoV-2 coronavirus and the 
incessant threat posed by endemic viral disease, the need for research and the exploration 
of coronavirus structure and function could not be more evident (Singhal 2020). 
Coronaviruses are responsible for thousands of deaths thus far in 2020 alone (Lake 2020). 
Before I elaborate on the idiosyncrasies of my thesis, I would like to provide some 
background information on viruses as a whole.  
Viruses are non-living, obligate intracellular parasites. Although they are not 
classified as living organisms, viruses exhibit some characteristics of life such as 
structurally organized genomes, the ability to adapt and mutate in response to 
environmental stress, and their reproductive potential though they still require a host to 
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facilitate replication (Maeda et al. 1995). Properties of life that viruses do not exhibit 
include metabolism and the ability to grow on their own. Because viruses are obligate 
intracellular parasites they require a host in order to undergo replication and facilitate any 
metabolic functions. They are also unable to maintain homeostatic conditions or actively 
respond to any changes stimuli. This is because viruses are in essence inert and subject 
only to the forces of Brownian motion when outside the host. Their susceptibility to 
Brownian motion can be attributed to the how small they are with respect to all living 
things on earth. Although previously a pathogen was only considered a virus if it was 
smaller than 0.2𝜇m, today there are no size parameters for what constitutes a virus as 
they range anywhere from 24nm in the bacteriophage MS2 to 300nm in a small pox 
virion(Griffiths 2000). It is worthwhile to note that there is no correlation in viral genome 
size and its pathogenicity or level of disease causing potential. Table I illustrates how 
small some species of virus are when compared to E. coli and red blood cells.  
It is necessary to point out that viruses are only referred to as viruses when they 
are inside of a host. When a virus is outside of its host, the viral particle is simply referred 
to as a virion (Griffiths 2000). Viruses account for the greatest genomic diversity on the 
planet. They are considered cosmopolitan as viruses can be found in every single niche 
and environment on the planet (Perlman and Netland 2009). This makes sense as one 
could expect one or more species of virus to exist for every single living organism on the 
planet (Yin and Wunderink 2018). Not all organisms may suffer from the adverse effects 
of a virus though. Some living species can be infected with a virus and be absent of any 
adverse symptoms or complications.  
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 Due of the pathogenic nature of human coronaviruses, in this study the viral 
system we utilized is known as mouse hepatitis virus or MHV. MHV exhibits high 
genetic and structural protein conservation to all previously identified HCOVs including 
the recently mapped SARA-CoV-2 strain (Mousavizadeh and Ghasemi 2020). The bulk 
of my research was oriented around a specific non-structural protein that is present in all 
coronaviruses known as Nsp5 (non-structural protein 5). Nsp5 is a protease whose 
responsibility is to make functional cleavages at 11 different amino acid sites after 
translation of the polyprotein(Baric et al. 1999). Within the genome of MHV resides a 
specific region that codes for the production of this protease. Additionally, an even more 
specific region of the sequence responsible for the translation of Nsp5 known as the 
interdomain loop (IDL) is thought to play a critical role in the functional activity of the 
protease as a whole (Stobart et al. 2012). Once the virus enters a host, the open reading 
frames begin to be translated as the protease Nsp5 cleaves the polyprotein while 
simultaneously activating the proteins that comprise it (Denison et al. 2011). It is thought 
that if the protease Nsp5 is rendered inactive that the virus as a whole will fail to replicate 
and perpetuate further infection. This preliminary hypothesis was first made by Stobart et 
al in 2012. 
 The vital role of the IDL though proposed has not been previously well 
characterized or studied. The focus of my work was based on characterizing the effects of 
site directed mutagenesis on the IDL and the ensuing implications that arise in terms of 
overall viral stability and replication kinetics. The IDL is located between the second and 
third domains of the Nsp5 dimer and includes residues P184, Y185, R186, D187, A188, 
Q189, V190, V191, Q192, L193, P194, V195, Q196, D197, and Y198. Our library of 
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MHV mutants was created by Stobart et. al during his work at Vanderbilt in Denison 
labs. From this mutant library I selected a panel of mutants to perform a series of 
experiments on. The overall aim of these experiments would be to characterize and better 
understand the role of Nsp5 and the implications its malfunction or functional absentness 
have on MHV replication. This included the analysis of replication kinetics through the 
generation of growth curves and plaque assays (n = 5). Further analysis consisted of the 
quantification of Nsp5 protein through performing western blots to determine if 
mutations results in reduced production or activity of the Nsp5 protease.  
 The discovery of novel mutations that render the virus unable to replicate 
effectively inside a host could serve as targets for therapeutics and drugs to treat the onset 
of coronavirus infections. Reducing the pathogenicity of coronaviruses through site 
directed mutagenesis could also be used to develop live attenuated vaccines or other 
preventative measures to establish immunity to coronavirus infection. In this study I 
present my findings on the residues of interest located in the interdomain loop that 
demonstrate suppressed replication kinetics under growth conditions with temperatures 
elevated from 37o C to 40oC. Specifically strains P184A and R186A exhibit diminished 
growth kinetics and contrasting cell morphology during the plaque assay experiments 
performed. The quantification of Nsp5 protein present in host cell lysates via western blot 
analysis allowed me to generate a comparative model contrasting the amount of Nsp5 
found in the putative temperature sensitive mutants P184A and R186A to that observed 
WT MHV strain.  
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TABLE I: Size comparison of various viruses with respect to E. coli and a human red 
blood cell. Viruses range in size and structure based on a multitude of both viral and host 
factors. The structures above are proportional to one another and help illustrate the 
immense variation in size between viruses and the living hosts they infect. Image copyright 
© 2006 by Pearson Scientific.   
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FIGURE 1: A phylogeny of all identified coronaviruses to date. The strains of 
coronavirus that are in a red font represent the human coronaviruses that have been 
identified to date. Within the green circle is MHV-A59 which is the coronavirus strain 
used in this study. *Absent from this phylogeny is Sars-CoV-2 due to its recent discovery 
and limitations on available information.  
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FIGURE 2:  Polyprotein structure of MHV with annotated cleavage sites. This figure 
shows the initial polyprotein that is translated via host cell machinery. Various open 
reading frames and gene regions code for the hallmark structures such as spike proteins 
for attachment, and E proteins for the formation of the viral envelope. Functional cleaves 
must be made by the protease in order for the proteins to fold and be active. If the 
polyprotein is not cut into its’ component parts the virus will not be able to yield an 
active infection in the host.  *Black triangles represent the 11 sites cleaved by the 
protease “Non-Structural Protein 5” (Nsp5). 
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FIGURE 3: PyMol protein cartoon (3A on the left) and ribbon (3B on the right) 
models of the Nsp5 protease. 3A is a general cartoon with the catalytic dyad region 
labeled in addtion to the N and C terminal regions of the protein.The Interdomain loop is 
found between domains 2 and 3 and is labeled with a black arrow above. 3B 
demonstrates the structural conservation between the MHV model, 3 of the 7 human 
coronaviruses that have been identified to date, and IBV which is an avian strain of 
coronavirus. The different colored ribbons corespond to the different strains. The legend 
for these coresponding strains and colors is below the image on the right. PyMol software 
was used for to generate the images depicted above.  
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Materials and Methods 
 
Cells and Virus Stock 
The cell line used in this study was DBT-9 (Delayed Brain Tumor-9) which is a neural 
cell line derived from mice. Virus stocks were provided by Dr. Stobart and initially 
created at Vanderbilt in conjunction with Denison Labs. 
 
Complete DMEM Recipe 
Complete DMEM was the media used for culturing cells and performing various assays 
throughout the duration of this research project. In recipe for this DMEM is included in a 
table below 
Ingredient Volume Purpose 
 
 
Dulbecco’s Modified 
Eagle’s Medium 
 
 
500mL 
Contains essential cell 
nutrients, building 
materials, salts, et cetera. 
Also contains a buffer 
agent that activates if the 
pH deviates too much from 
its initial value 
 
Fetal Bovine Serum 
 
50mL 
Additional nutrients 
needed for cell growth and 
replication 
 
Amoxicillin/Amphotericin 
mix 
 
5mL 
Limits the onset of 
microbial contamination in 
the form of antibiotics and 
antimycotics 
 
1 Molar HEPES Buffer 
 
5mL 
pH buffer that will help 
ensure optimum conditions 
for replication  
 
 
Glucose 
 
 
10mL 
Augments the amount of 
available nutrients and 
provides the complex 
sugars needed to drive cell 
metabolism 
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Time Course & Plaque Assays 
DBT-9 cells were grown in 6 well plates and infected with virus with an Multiplicity of 
Infection (MOI) of 0.01. Infected plates were incubated at 37oC and 40oC for 32 hours. 
Aliquots were harvested for each strain at hours 0, 4, 8, 12, 16, 24, and 32 and stored in a 
-80oC freezer for later analysis. 
 
Efficiency of Plating 
Efficiency of plating (EOP) experiments were performed to determine the ability of 
viruses to replicates at different temperatures. P184A, R186A, A188I, V190I, V191I, 
P194A, Q196A, and Y198A were plated in addition to the wild type MHV strain and 
temperature sensitive control strain S133A. 12 well plates confluent with DBT-9 cells 
were infected with 50𝜇l of virus stocks and diluted with 270𝜇𝑙 of gel saline. A gel 
overlay consisting of 50% agar solution (4% agarose by mass) and 50% complete 
DMEM was placed in each well after infection. Gel overlay volume per well was 500𝜇𝑙. 
Plates were incubated for 24hours at 37oC or 40oC. After incubation, gel plugs were 
removed, and plaques were fixated for 20 minutes using a 4% formaldehyde solution. 
Residual gel and liquid were aspirated after 20 minutes and plates were left to air dry. 
After plates have dried the plaques were counted in order to determine the viral titers for 
each strain respectively. 
 
Growth Curves 
The growth curve assay was a multi-phase experiment. Phase I consisted of infecting 6 
well plates that were confluent or near confluent (>90% surface area covered) with DBT-
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9 cells. The strains used for the growth curve assay include P184A, R186A, A188I, 
V190I, V191I, P194A, Q196A, and Y198A in addition to the wild type MHV strain. 
Infection volumes were normalized for each strain to ensure a consistent MOI of 0.01. 
Well volumes were brought up to 2mL with complete DMEM to ensure ample cell 
nutrients and optimum conditions for viral infection. After infection, 100𝜇𝐿 aliquots were 
harvested at time points 0, 4, 8, 12, 16, 24, and 32 (hours). Samples were then store in the 
-80oC freezer to be tiered in phase II of the growth curve assay.  
Phase II of the growth curve assay consisted of tittering the 7 aliquots taken for 
each of the 9 strains that were plated. Because the infection volumes were normalized, 
the relative MOI of each strain post incubation or harvesting is not germane to 
subsequent analysis. Aliquots were thawed and tiered with the same protocol outlined in 
the EOP assay. Plates were infected, gel overlays were added, and the plates were 
allowed to incubate for 24 hours at 37oC to determine if any of the aliquots exhibited 
suppressed viral replication during phase I and thus yield lower titers during after 
incubation in phase II. The assay was performed in triplicate and the calculated titers 
were averaged for each respective time point. 
 
 
Western Blots 
The western blot assay was attempted several times, but only successfully completed start 
to finish one time. Early steps of the western blot consisted of harvesting virus lysates to 
be later processed in gels. Putative temperature sensitive mutants P184A and R186A 
were the only mutants used in this study. Wild type and known temperature sensitive 
 
 
 
Nick 18 
mutant S133A were also used in this assay as controls. 6 well plates confluent with DBT-
9 cells were infected with an MOI of 0.10. Plates were incubated overnight at either 37oC 
or 40oC. Wells were aspirated and then rinsed with PBS. After being rinsed each well 
received 1mL of RIPA buffer. Lysates were incubated on ice for 30 minutes and agitated 
every 5 minutes to ensure the proteins are uniformly denatured. After lysates have been 
harvested they are centrifuged at 1000xG for 5 minutes at 4oC. The RIPA is aspirated 
leaving behind a pellet in the tube. Re-suspend the pellet in 1mL of PBS and centrifuge 
again at 13K rpm for 20 minutes. After this spin transfer the supernatant to a new tube 
and either store it at -80oC or proceed to the next phase of the western blot assay. 
Once lysates were harvested, I began to prepare the gels to be loaded and ran. The gel run 
portion of the assay consisted of loading each well with 60𝜇L of lysate, 12 𝜇L of DTT, 
78 𝜇L of loading dye, and 30 𝜇L of water for a total volume of 180 𝜇L. This was the 
necessary volume because this protocol was done in triplicate for each trial to provide 
western blots that look for proteins from Nsp2, Nsp5, and Nsp8 in each replicate. The gel 
rig was filled with tris running buffer to ensure the necessary ions are in solution to create 
a current and allow the proteins to migrate through the gel. Wells were loaded with 
50𝜇l of each lysate with the supplemental DTT, loading dye, and water. 5𝜇L of ladder 
were added to well one of each gel. Once gels were loaded they were run for at 95 volts 
for an hour or until all of the proteins had migrated to the bottom of the gel in a uniform 
line.  
After gels were run, proteins were transferred onto nitrocellulose papers over the course 
of an additional hour. Sponges, filters, and transfer paper were layered on both sides of 
the gel. The rig was filled with a 50-50 methanol/tris buffer solution for the transfer step. 
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Nitrocellulose was activated in pure methanol prior to insertion into the gel cassette. The 
entire gel rig is to be surrounded in ice in addition to ice packs being placed in the rig to 
keep the exothermic transfer reaction cool. After the transfer is complete the 
nitrocellulose paper that now contains the viral proteins from the lysates can proceed to 
the blocking step. 
Transfers were blocked in 5% powdered milk solution made with TBST that was 
supplemented with sodium azide to ensure sterility and prevent any contaminants from 
denaturing the proteins or compromising the later step of imaging. Transfers were rocked 
at 4oC for 1 hour in the presence of the primary antibody. They were then rinsed three 
times with PBS to remove residual antibody and rocked again under the same conditions 
but in the presence of a secondary antibody which was either 15𝜇L of Nsp2, 15𝜇L of 
Nsp5, or 10𝜇L Nsp8. After the second blocking step was complete, transfers were treated 
with 160𝜇L a mix of LSB and BME. A master mix was created consisting of 282.3𝜇L of 
LSB and 31.3𝜇L of BME. After treatment with the BME/LSB mix the transfers were 
quickly transitioned into the imaging phase. 
 
Reversion Analysis 
Reversion analysis began with first procuring a T75 flask confluent with DBT-9 cells. 
The flask was then passaged into four T25 flasks that were also allowed to grow to 
confluency before being infected with 2𝜇L of viral stock. Every 24 hours 10𝜇L was 
extracted from the previous T25 flask and injected into a new T25 flask that was also 
confluent in DBT-9 cells. Residual media was removed and placed in 1.5mL conicals for 
storage in the -80oC freezer. 350𝜇L of RNA lyser was added to each flask on days 1, 3, 
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and 5 (after the initial aliquot was harvested and the infection of the subsequent flask is 
performed). Flasks were rocked for 60 seconds after addition of the RNA lyser to ensure 
uniform distribution before taking a 350𝜇L aliquot for each flask and storing it with the 
other aliquots at -80oC.  
  
 
 
 
Nick 21 
Results 
 
Loop Conservation 
It is known that the genome of all coronavirus species that have been sequenced to date 
exhibit high amounts of conservation both in regard to their nucleotides and the resulting 
proteins that form upon translation. This is especially true for the coding and structure of 
the protease Nsp5. Figure 3 depicts a carton graphic of the protease in MHV and also 
shows a ribbon alignment of multiple different strains of coronavirus and the resulting 
morphological and structural conservation in the amino acids that comprise them. This 
alignment demonstrates that with respect to the IDL, the molecular morphologies are near 
indistinguishable. 
 
Mutagenesis 
Prior to the testing and analysis of MHV through growth curves, temperature stability 
assays, etcetera I had to select what strains of MHV I wanted to use. The available 
mutants in house were created by Dr. Stobart during his time spent at Vanderbilt working 
under the direction of Dr. Mark Denison. They used Site directed mutagenesis  to mutate 
residues of interest in the interdomain loop and observe the resulting impact. The specific 
protocol for the generation of the mutant strains was unavailable and deemed non-
germane to the integrity of the study. Mutants were sequenced to ensure their genetic 
composition. Table 1 shows the results of the mutagenesis experiments performed. The 
recovered mutants include P184A, R186A, A188I, V190I, V191I, P194A, Q196A, and 
Y198A. The unrecovered mutants include Y185A, D187A, Q192A, and T199A. Those 
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residues in the interdomain loop that are to date yet to be mutated and subsequently 
analyzed include Q189, L193, V195, and D197. All of the viruses that were recovered 
were used for subsequent characterization and analysis. 
 
Efficiency of Plating and Temperature Sensitivity 
Initial characterization of the selected mutants required performing an efficiency of 
plating assay. All recovered strains including P184A, R186A, A188I, V190I, V191I, 
P194A, Q196A, and Y198A were plated in addition to the wild type MHV strain and 
temperature sensitive control strain S133A. Because Nsp5 is known to be subject to 
temperature sensitive mutations, I wanted to perform an exhaustive analysis to determine 
if any of the mutants are sensitive to changes in temperature. Results are shown in figure 
4. A ratio of the viral titer at 40oC to the titer at 37oC is portrayed. Any strain that 
exhibited an EOP of < 0.01 was considered a temperature sensitive mutant. Those strains 
that fell under the temperature sensitive parameters include P184A, R186A, and the 
temperature sensitive control S133A. P184A and R186A had EOP values of about .01 
and .001 respectively while the temperature sensitive mutant had an EOP of 10*10-4.3. 
The EOP experiment had an N = 3 and the error bars represent the standard deviation of 
each EOP replicate. (Each replicate consisted of growing a plate at 37oC and 40oC) 
 
Replication Kinetics 
After the identification of two putative temperature sensitive mutants, I proceeded with 
performing a series of growth curve experiments to quantify the viral replication kinetics 
of each strain, both temperature sensitive and not, at 37oC and 40oC. Because of the 
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previous knowledge that Nsp5 mutant can be temperature sensitive, it was thought that 
this assay would capture any deficiencies in a strain’s replication kinetics. Figure 5 
illustrates my evaluation of the replication kinetics of the various strains at 37oC and 
40oC.  In regard to the 37oC assay, there is not much deviance in any one strain from the 
linear pattern that’s observed. This assay was done in replicate twice while the 40oC 
assay had an N = 4. On the 40oC I observed suppressed growth kinetics in both P184A 
and R186A. Time points hour 8 and hour 12 for P184A should delayed and diminished 
growth kinetics. R186A exhibited more profound suppression than P184A with even 
lower titers quantified in replicate at hours 8, 12, and 16. 
 
Western Blot 
 To further demonstrate that it was the mutations to Nsp5 coding interdomain loop 
that resulted in the suppressed replication kinetics, I elected to perform a western blot 
assay to quantify the relative amount of Nsp5 protein present in cultures grown at 
different temperatures. Due to time constraints and the onset of Covid-19, completion of 
multiple replicates was not possible. Figure 6 however depicts the single successful 
western blot that I was able to perform. Though it does not provide sufficient evidence to 
further the previous claims that P184A and R186A are thermal sensitive mutants, it does 
allude to the potential for this experiment to provide additional evidence if it is performed 
again in future directions or in future replicates to supplement the data presented here. 
The figure shows the percent of Nsp5 protein quantified for each species. The 
percentages were normalized to wild type and exhibited 89%, 11%, and 86% as much 
protein as the WT strain for S133A, P184A, and R186A respectively. 
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Reversion Analysis 
Another means of identifying residues that a virus deems essential for maintaining 
normal structure and function is through reversion analysis.  R186A is the most likely 
putative thermal-sensitive mutant which is why it was selected for additional analysis via 
a reversion assay at 40oC. After culturing R186A at 40oC and passaging 10 times, 9 
plaques were picked from the plate at random and sent off for sequencing. Sequencing 
reveal that the R186A mutant had not reverted directly but mutated additional residues 
within the interdomain loop or in close proximity. The observed mutations after reversion 
P184S, L141V, and L141I.
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TABLE 2: A graphic depicting all of the recovered, unrecovered, and attempted 
mutant strains of Murine Hepatitis Virus used in this study. Strains in the “Recovered 
Mutants” column represent the site directed mutations that resulted in a virus that was 
functional and able to undergo replication. “Unrecovered Mutants” represents the strains 
that upon mutating were either unable to infect or replicate within a host. Recovery was 
attempted three times before a strain was classified as unrecoverable. Strains listed in the 
“Unattempted” column represent putative mutations that may or may not result in 
suppressed viral growth kinetics or a diminished ability to infect a host. 
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FIGURE 4: Efficiency of plating experiment for initial characterization of mutant 
library. The strains presented in the figure above include both controls and mutated 
strains. S133A is a previously identified thermal-sensitive mutant. This experiment was 
performed in triplicate and the errors bars represent the average standard deviation in 
EOP values for the three assays performed. The scale on the right represents the viral tire 
amount at 40oC divided by the titre at 37oC. It ranges in values from 10-5 to 101.   
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FIGURE 5: Growth curves of MHV mutants under 37oC and 40oC. 5A represents the 
results of the experiment performed at 37oC and 5B represents the results of the 
experiment performed at 40oC. The temperature sensitive control known S133A was not 
included in this experiment. N = 2 and N = 4 for figures 5A and 5B respectively. The 
error bars represent the average standard deviation values within replicates. 
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FIGURE 6: Western blot analysis of putative thermal mutants to quantify the  
amount of Nsp5 protein present in MHV cultures grown at 37oC and 40oC. The band 
saturations were normalized to the WT strain and presented below the strain that they 
correspond to. Bands at 37oC were then compared to those at 40oC to identify any 
deficiency in protein production at elevated temperatures. Though several attempts were 
made only one trial was successful in the performance of the western blot assay (N = 1).   
  
Mock
WT
37C 40C
S133A
37C 40C
P184A
37C 40C
R186A
37C 40C
Normalized 
Ratio to WT:
100% 89% 11% 86%
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FIGURE 7: Graphic depicting the general procedure of the reversion analysis assay. 
Reported are the detected mutations L141V, L141I, and P184S. These were all novel 
mutations discovered upon amplification and sequencing after the reversion analysis 
assay was complete. This figure serves to outline the general procedure performed and 
presents only qualitative evidence.  
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FIGURE 8: A Cartoon of the Nsp5 protease with the detected reversion mutants 
P184S, L141I, and L141V highlighted. Arrows emphasize the potential interactions that 
could be taking place between R186A and the reversion mutant residues. This carton was 
created and manipulated using PyMol software. Because two separate mutations were 
detected at the same residue, the L141I and L141V mutants share the same residue 
location on the figure above.   
 
 
 
Nick 31 
Discussion 
With the recent emergence of SARS-CoV-2 and its associated disease Covid-19, 
the 7th identified human coronavirus to date, the need for pre-emptive research on 
pathogenic viruses is of vital importance to the human population. Because of the high 
conservation of structure and function within all species of coronaviruses, the exploration 
of temperature sensitive mutants could offer up novel insight that could be used for the 
development of targeted therapeutics and treatments for those who have coronavirus 
infections.  
 This study was initiated by previous discoveries made by Stobart et. al. that 
pertain to site directed mutagenesis in domain 1 of MHV which is the location of the 
active site of the protease NSP5. Mutations in key residues resulted in unrecoverable 
mutants. This led to the investigation of the role of the other domains (and their 
compositional residues) compromising NSP5. More specifically, the protein region 
located between domain II and domain III referred to as the interdomain loop. Although 
the function of this loop has not been previously characterized, I hypothesized that this 
region plays a direct and critical role in the overall structure and function of NSP5.  
 Initial experiments consisted of an exhaustive analysis of the mutant strains that 
were available for characterization. The aim here was to determine whether or not the 
mutants were compromised or recoverable and able to exhibit normal replication kinetics 
at elevated temperatures. I performed an efficiency of plating assay that consisted of 
infecting DBT-9 cell cultures with each of the recovered mutants illustrated in Table 1. 
Strains that had an EOP of 0.1 or less were determined to be temperature sensitive 
mutants and candidates for further characterization. Strains P184A and R186A both 
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exhibited suppressed replication kinetics at 40oC compared to 37oC. P184A’s EOP of .01 
and R186A’s EOP of .001 both suggest that these strains are of putative thermal 
sensitivity.  
 After initial characterization the next step was to perform a time course 
experiment to observe the replication kinetics and the resulting patterns or trends that 
arise in the different strains at different temperatures. Yet again I maintained the 
conditions of 37oC and 40oC and infected plates with an MOI of 0.01 for each strain 
respectively. After samples were harvested at the time points depicted in figure 5, they 
were later thawed and used to titer the harvested aliquots of each strain to determine the 
PFU/mL ratios of each strain with respect to time and temperature. Figure 5 shows the 
results of this experiment. Collectively At 37oC I observed graphical linearity which is 
indicative of a conserved ability to replicate effectively in all strains at this temperature. 
At 40oC however, yet again I observed suppressed replication kinetics in P184A and 
R186A. A more profound effect was observed in R186A; more specifically from hour 4 
to hour 16 one can see a quantifiable deficiency in R186A’s ability to replicate efficiently 
compared to the other strains. Eventually R186A begins to catch up with the other strains 
in terms of kinetics as observed from hour 16 to hour 20. This could be due to MHV 
undergoing spontaneous mutagenesis after exposure to the elevated temperature. 
Mutations could have reverted the initial mutation back to its initial residue. It could also 
have resulted in other residues mutatating that play an indirect role in protease function to 
compensate for any deficiencies that arose from the initial mutation at Arginine 186.  
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 Following initial analysis and supplemental characterization of the novel mutants 
available, I was able to deduce that of the panel 8 putatively temperature sensitive strains, 
P184A and R186A are the most likely candidates for further study.  
 As previously stated, upon translation of MHV, the resulting polyprotein must be 
cleaved by NSP5 into its respective functional protein units and structures. To further 
demonstrate that NSP5 activity is suppressed at 40oC, I performed a western blot of the 
WT strain, P184A, R186A, and the previously identified thermosensitive mutant S133A. 
The aim of this experiment was to quantify and observe the activity of NSP5 and its 
ability to cleave polyproteins at 40oC compared to 37oC. The antibody used for the 
western blot procedure is designed to tag NSP5 protein and determine its relative 
abundance in the viral lysates I harvested. As anticipated, I saw diminished levels of 
NSP5 proteins present in 184A and 186A compared to the wild type band. This suggests 
that the mutations incorporated into these MHV strains resulted in less NSP5 protease 
being produced. One could infer from this evidence that suppressed replication kinetics 
and reduced levels of NSP5 proteins can be attributed to these mutations. Furthermore, 
the previously presented evidence in the EOP and time course experiments compounded 
with the data uncovered from the western blot suggest that P184A and R186A likely play 
a direct role in the structure or function of NSP5.  
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Conclusion 
The aim of my research when I first began working with Mouse Hepatitis Virus 
was to characterize the interdomain loop and determine if any of the residues that 
comprise it could inactive the essential MHV protease Nsp5 and render the virus unable 
to replicate. Through extensive research and an exhaustive analysis of the mutant strains I 
had available, I was able to identify residues in the interdomain loop that could serve as 
putative targets for therapeutics or drugs. After this research is can proposed that strains 
P184A and R186A possess mutations that result in suppressed viral growth kinetics at 
elevated temperatures. The specific role of these residues within Nsp5 remains 
unresolved. The occurrence of various molecular interactions with adjacent residues or 
those in close proximity to P184A and R186A can be implied, but it remains unknown 
what biochemical interactions or processes are interrupted by these mutations in the IDL. 
It is also possible that mutations to the coding region for Nsp5 have indirect implications 
that compromise some other aspect of viral replication (or one of the multiple steps that 
comprise the process). Future replicates of the western blot assay are needed to be 
performed before I can objectively claim that it is exclusively the dysfunction of Nsp5 
that is resulting in the suppressed viral replication. 
As the spread and persistence of Covid-19 continues to plague the international 
population, research such as that presented in this study demonstrates the importance of 
funding and carrying out undergraduate research (Singhal 2020). While no undergraduate 
may have the knowledge or resources to develop a vaccine or find a cure to a disease, 
they do have the potential to make appreciable contributions to any number of fields that 
can support scientists who do have the resources and the knowledge. I started researching 
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coronaviruses 2 years before they became center stage in regard to global health. I did so 
not because I knew society would be facing a pandemic in the foreseeable future, but 
because I knew that one day it could. Providing funding and support for undergraduate 
research is be of great value. Students like myself and the many more in my lab in 
undergraduate labs around the world can be proactive and provide answers to questions 
and resolutions to problems long before they reach the extent that Covid-19 has. 
 In conclusion, Mouse Hepatitis Virus is a valuable model organism that has 
revealed much about the structure and function of coronaviruses in general. The 
interdomain loop does play a significant role in dictating the functional capacity of the 
essential MHV protease Non-structural protein 5. It is my hope that the research 
presented in this thesis is of benefit to those in the coronavirus field, and can be expanded 
on by investigators who have the resources and the intellect necessary to take these 
findings to the next level. I am optimistic that the research I began will be continued as 
there is much work and exploration that remains undone both with respect to MHV and 
with coronaviruses in general.   
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Future Directions 
 
Future directions for this thesis would first and foremost seek to perform more 
replicates of the experiments discussed here. Specifically, more replicates of the growth 
curves presented in figure five and also the western blot are in need of additional 
replicates to be performed in order to augment the credibility and affirm the current 
evidence presented in this thesis. An expansion of the tested temperatures for the growth 
curve assays would also be of benefit to see if slight changes below 37oC or above 40oC 
would result in any additional suppression. Similar protocol would be used but 
temperatures could fall 1 or 2 degrees above and below the temperatures used in the 
experiments I performed.  I hypothesize that this would result in higher deficiencies of 
viral replication in the two-putative temperature sensitive mutant P184A and R186A. It is 
also possible that the additional stress introduced to the virus could shed light on other 
residues that are maybe less sensitive than P184A or R186A to changes in temperature 
but exhibit less efficient viral replication that is statistically significant when compared to 
the replication potential of other strains at the same temperature. 
Protein crystallization is another future direction that I considered exploring during my 
research time. Current protein models of MHV are limited to the wild type strains. Files 
can be retrieved from the protein data base that contain a sequenced and proposed model 
of the protease Nsp5, but this model only shows the interactions that take place in the 
wild type strain. I suggest the development and performance of a protein crystallization 
assay that can be used to observe and characterize the molecular interactions that result 
after site directed mutagenesis. The construction of these crystal structures would provide 
profound insight into the biochemical interactions that the virus considers to be of critical 
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importance for its replication and survival. These models could also be of benefit for the 
exploration of targeted therapeutics and the development of treatments for combatting 
coronavirus infections. Though the development of drugs for treatment of MHV in mice 
has no direct benefits to people, because of the high conservation of structure and 
function observed in all species of coronavirus, the successful development of 
therapeutics for MHV would mean that those same therapeutics and residues could be 
used for treatment in people.  
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